Skip to main content
. 2017 May 30;2017(5):CD010172. doi: 10.1002/14651858.CD010172.pub2
Completed by  
Date  
Study ID  
Methods Study design:
Multicentre or single‐centre:
Country:
Study aim:
Participants Total number of participants:
Setting (type of ICU; country):
Inclusion criteria:
Exclusion criteria:
Study aim (specify whether intervention is given for respiratory failure, post‐extubation etc.)
Baseline characteristics
Intervention group

  • Age, (years) mean (SD):

  • BMI (kg/m2) mean (SD):

  • Respiratory rate (breaths/min) mean (SD):

  • PaCO2 (mmHg) mean (SD):

  • PaO2/FiO2 (mmHg) mean (SD):

  • Illness severity score (such as APACHE II) mean (SD):


Comparison group

  • Age, (years) mean (SD):

  • BMI (kg/m2) mean (SD):

  • Respiratory rate (breaths/min) mean (SD):

  • PaCO2 (mmHg) mean (SD):

  • PaO2/FiO2 (mmHg) mean (SD):

  • Illness severity score (such as APACHE II) mean (SD):
Interventions Intervention group

  • Randomized, n = ; losses (with reasons) = ; analysed, n =

  • Details (include type of device; size of nasal cannulae; flow rate; duration; washout period in cross‐over studies):


Comparison group

  • Randomized, n = ; losses (with reasons) = ; analysed, n =

  • Details (include type of device; flow rate; duration; washout period in cross‐over studies):
Outcomes Outcomes measured/reported by study authors:
Outcomes relevant to the review:
Outcome data If study is a cross‐over design, are the data reported separately for the first cross‐over period
Notes Funding/declarations of interest:
Study dates:
Additional notes: